| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
1999-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fbc879b8c0161522709eaa40d8c3a02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef6039c09e675fe43c606a36b5a891f9 |
| publicationDate |
2001-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6291637-B1 |
| titleOfInvention |
Interference with viral IRES-mediated translation by a small yeast RNA reveals critical RNA-protein interactions |
| abstract |
Peptides and RNA oligonucleotides and methods of use for the inhibition of translation of an mRNA, which is initiated at an internal ribosome entry site of the mRNA and requires binding of a protein factor to that site, are disclosed. Peptides comprising the La autoantigen binding domain (LAP) are disclosed. LAP peptides alone or in combination with inhibitor RNA oligonucleotides (IRNA) may be used as antiviral agents to inhibit internal ribosome entry site (IRES) mediated viral replication. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100658506-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1872125-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008318222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1872125-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841073-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012125306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013036622-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013036622-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003143247-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013163404-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9068969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009067191-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009067191-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8420617-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005227251-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011076676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009247455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03063888-A1 |
| priorityDate |
1994-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |